These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29472921)

  • 1. Kinetics of HIV-Specific CTL Responses Plays a Minimal Role in Determining HIV Escape Dynamics.
    Yang Y; Ganusov VV
    Front Immunol; 2018; 9():140. PubMed ID: 29472921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time Intervals in Sequence Sampling, Not Data Modifications, Have a Major Impact on Estimates of HIV Escape Rates.
    Ganusov VV
    Viruses; 2018 Feb; 10(3):. PubMed ID: 29495443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection.
    Ganusov VV; Goonetilleke N; Liu MK; Ferrari G; Shaw GM; McMichael AJ; Borrow P; Korber BT; Perelson AS
    J Virol; 2011 Oct; 85(20):10518-28. PubMed ID: 21835793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mathematical modeling of escape of HIV from cytotoxic T lymphocyte responses.
    Ganusov VV; Neher RA; Perelson AS
    J Stat Mech; 2013 Jan; 2013():P01010. PubMed ID: 24660019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad CTL Response in Early HIV Infection Drives Multiple Concurrent CTL Escapes.
    Leviyang S; Ganusov VV
    PLoS Comput Biol; 2015 Oct; 11(10):e1004492. PubMed ID: 26506433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response.
    Jones NA; Wei X; Flower DR; Wong M; Michor F; Saag MS; Hahn BH; Nowak MA; Shaw GM; Borrow P
    J Exp Med; 2004 Nov; 200(10):1243-56. PubMed ID: 15545352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
    Cardinaud S; Consiglieri G; Bouziat R; Urrutia A; Graff-Dubois S; Fourati S; Malet I; Guergnon J; Guihot A; Katlama C; Autran B; van Endert P; Lemonnier FA; Appay V; Schwartz O; Kloetzel PM; Moris A
    PLoS Pathog; 2011 May; 7(5):e1002049. PubMed ID: 21589903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating Costs and Benefits of CTL Escape Mutations in SIV/HIV Infection.
    Ganusov VV; De Boer RJ
    PLoS Comput Biol; 2006 Mar; 2(3):e24. PubMed ID: 16604188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The route of HIV escape from immune response targeting multiple sites is determined by the cost-benefit tradeoff of escape mutations.
    Batorsky R; Sergeev RA; Rouzine IM
    PLoS Comput Biol; 2014 Oct; 10(10):e1003878. PubMed ID: 25356981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of immune escape during HIV/SIV infection.
    Althaus CL; De Boer RJ
    PLoS Comput Biol; 2008 Jul; 4(7):e1000103. PubMed ID: 18636096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notwithstanding Circumstantial Alibis, Cytotoxic T Cells Can Be Major Killers of HIV-1-Infected Cells.
    Gadhamsetty S; Coorens T; de Boer RJ
    J Virol; 2016 Aug; 90(16):7066-7083. PubMed ID: 27226367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.
    Karlsson AC; Iversen AK; Chapman JM; de Oliviera T; Spotts G; McMichael AJ; Davenport MP; Hecht FM; Nixon DF
    PLoS One; 2007 Feb; 2(2):e225. PubMed ID: 17311088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response.
    Troyer RM; McNevin J; Liu Y; Zhang SC; Krizan RW; Abraha A; Tebit DM; Zhao H; Avila S; Lobritz MA; McElrath MJ; Le Gall S; Mullins JI; Arts EJ
    PLoS Pathog; 2009 Apr; 5(4):e1000365. PubMed ID: 19343217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
    J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection.
    Hay CM; Ruhl DJ; Basgoz NO; Wilson CC; Billingsley JM; DePasquale MP; D'Aquila RT; Wolinsky SM; Crawford JM; Montefiori DC; Walker BD
    J Virol; 1999 Jul; 73(7):5509-19. PubMed ID: 10364299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of antiviral activity by human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL) and rapid selection of CTL escape virus in vitro.
    Van Baalen CA; Schutten M; Huisman RC; Boers PH; Gruters RA; Osterhaus AD
    J Virol; 1998 Aug; 72(8):6851-7. PubMed ID: 9658134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Epitope Variability Is Associated with T Cell Receptor Repertoire Instability and Breadth.
    Balamurugan A; Claiborne D; Ng HL; Yang OO
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.
    Sunshine JE; Larsen BB; Maust B; Casey E; Deng W; Chen L; Westfall DH; Kim M; Zhao H; Ghorai S; Lanxon-Cookson E; Rolland M; Collier AC; Maenza J; Mullins JI; Frahm N
    J Virol; 2015 Oct; 89(20):10303-18. PubMed ID: 26223634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
    Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8
    Kim J; De La Cruz J; Lam K; Ng H; Daar ES; Balamurugan A; Yang OO
    Viral Immunol; 2018 Sep; 31(7):525-536. PubMed ID: 30059271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.